GT20029 showed significant hair growth and safety in phase II trials, with no adverse sexual events. Users are hopeful but concerned about future costs and systemic effects.
Users discuss waiting for new hair loss treatments and share struggles with sideeffects from current options like Minoxidil and Finasteride. They express hope for Pyrilutamide and CosmeRNA to provide better solutions.
The post is about whether there is any additional benefit to using alfatradiol or other estrogen treatments for hair loss if someone is already using finasteride, dutasteride, or an androgen receptor inhibitor like RU58841, pyrithione zinc, or fluridil.
A user has been using sublingual minoxidil for hair loss due to difficulty obtaining pills and is concerned about cancer risk from ethanol exposure. Other users advise against this method, suggesting topical application instead, and debate the potential risks of ingesting topical minoxidil.
Pyrilutamide, a new drug being tested to combat hair loss that has been found to perform comparably or better than finasteride and dutasteride in the initial 6 months of treatment with minimal reported sideeffects.
Switching to dutasteride as a hair loss prevention treatment, along with minoxidil, dermarolling and nizoral shampoo, and the potential benefits and sideeffects of using finasteride and/or dutasteride in combination with topical anti-androgens like RU58841.
After taking finasteride for 192 days, the user experienced sideeffects like depressed mood and decreased libido, along with worsening hair thinning and scalp issues. Despite consulting a dermatologist, the user's hair condition and scalp itchiness have not improved.
Some users have experienced good hair regrowth with estradiol, cyproterone acetate, spironolactone, and bicalutamide, but these treatments may cause feminization and other sideeffects. It's advised to consult a doctor before using these treatments, as they can lower testosterone and have significant risks.
The user experienced increased hair shedding after adding tretinoin to their regimen of finasteride, minoxidil, and dermarolling, but noticed new vellus hairs appearing. They plan to restart tretinoin more gently, as some users suggest shedding indicates treatment effectiveness, while others warn it may cause severe thinning for a minority.
The user is considering adding RU58841 to their current hair loss treatment of finasteride and minoxidil, but is concerned about potential sideeffects like hairline recession and shedding. Some users report positive results with RU58841, while others experience sideeffects such as chest pain and dizziness.
Dutasteride is associated with increased blood glucose, HbA1c, LDL cholesterol, and liver enzyme activity, potentially leading to diabetes, NAFLD, and liver metabolism changes. The conversation highlights concerns about these adverse effects and calls for more studies, including on finasteride.
The user shared progress pictures after using topical finasteride, minoxidil, and tretinoin for about 9 months, along with weekly microneedling, cold showers, and a diet free of processed foods. They reported no sideeffects.
People are discussing hair loss treatments, including pyrilutamide, minoxidil, dutasteride, alfatradiol, and bimatoprost. Users share their experiences and sideeffects, noting that pyrilutamide is considered more effective and safer than RU58841.
A user is excited to start using Pyriltamide for hair loss after experiencing sideeffects from topical finasteride. Other users discuss the potential and skepticism of Pyriltamide compared to older treatments like finasteride and RU58841.
A user is concerned that using rosemary oil after microneedling might cause gynaecomastia due to increased absorption and potential DHT blocking. Other users believe rosemary oil is unlikely to affect hormones or cause gynaecomastia.
Switching from oral to topical dutasteride can cause shedding due to changes in DHT levels, and it's recommended to overlap both treatments to minimize this effect. Topical dutasteride may cause scalp irritation, and the user is considering dutasteride mesotherapy as an alternative.
The user experienced significant hair regrowth and improved hair health using topical minoxidil, oral finasteride, microneedling, and ketoconazole shampoo. Other users discussed the effectiveness and sideeffects of finasteride, dutasteride, and RU58841, with some expressing concerns about potential sideeffects.
A female user is considering using RU58841 with minoxidil 2.5% to reduce sideeffects like facial hair from minoxidil 5%, while also using copper peptides and a hair serum. Other users discuss alternative treatments like spironolactone, alfatradiol, and the sideeffects of finasteride.
The user shared their hair loss treatment routine, which includes caffeine shampoo, The Ordinary Hair Serum, red light therapy, topical finasteride, topical minoxidil, Nizoral shampoo, and dermarolling. They previously used oral finasteride but stopped due to travel, resulting in rapid hair loss.
The conversation is about the lack of improvement in hair loss after using Pyrilutamide for 14 weeks, with the original poster unable to use Finasteride due to depression. Replies suggest that Pyrilutamide, like RU58841, may not work for everyone, and a more potent drug is being developed by Kintor.
Switching from finasteride to dutasteride and back to finasteride led to gynecomastia and fatigue, likely due to hormonal imbalances. Suggested treatments include Tamoxifen, Raloxifene, or low-dose Anastrozole, with a recommendation to test testosterone and estradiol levels.
RU58841 is used topically to prevent hair loss by blocking DHT, with suggestions to drink grapefruit juice, take breaks, avoid microneedling, and use lower concentrations to reduce sideeffects. Users discuss applying it at night to minimize systemic absorption.
The user is experiencing breast tissue growth from taking dutasteride and minoxidil, and is considering reducing the dosage or stopping the medication. Suggestions include seeing an endocrinologist, using Raloxifene or Arimidex, and considering topical treatments or surgery if necessary.
User discussed hair loss treatments like Minoxidil, Finasteride, RU58841, and microneedling. They talked about sideeffects, effectiveness, and their current plan using low-dosage Finasteride and Dutasteride.
A user experienced severe sideeffects from using topical minoxidil sublingually, including muscle cramps, dizziness, and high potassium levels. They were advised to stop and seek medical help, emphasizing that topical minoxidil is not safe for ingestion due to its alcohol content.
The user mixed RU58841 with Minoxidil for hair loss treatment and experienced reduced hair fall and thicker hair but stopped due to chest pain and muscle twitching. They plan to use a new routine without RU58841 or Finasteride due to sideeffects, including various topical treatments and peptides.
The conversation is about using pyrilutamide and RU58841 as topical solutions to prevent hair loss. Pyrilutamide is considered safer but less potent than RU58841, which some users find effective despite potential sideeffects like heart palpitations.
The conversation is about choosing an anti-androgen for hair loss treatment, with options being alfatradiol and pyrilutamide. Alfatradiol is considered a better choice due to its established use, while pyrilutamide is more experimental.
The user has been using oral dutasteride (DUT) for 1.5 years but is experiencing hair thinning again and is considering increasing the dose or adding topical treatments like RU58841, despite concerns about sideeffects. Suggestions include trying oral minoxidil or waiting to see if the thinning is just a temporary shed.